Abstract
ObjectiveTo characterise the temporal evolution of antibodies to infliximab (ATI).DesignProspective observational study of infliximab-treated patients with inflammatory bowel disease between 2009 and 2012.InterventionsTrough levels of infliximab and ATI were measured...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have